Design
Review
Authors
Loading...
Provides mechanistic overview of central antihypertensives; leaves open comparative effectiveness research in resistant hypertension.
Centrally acting antihypertensive drugs lower blood pressure through diverse central mechanisms including alpha-2, imidazoline I1, and 5HT1A receptors.
P. A. van Zwieten (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: